Lillys
-
USA
The market likes what it heard from the Fed — plus, Lilly’s new $6B manufacturing investment
Every weekday, CNBC Investment Club with Jim Cramer publishes Homestretch, an actionable afternoon update just in time for the final…
Read More » -
USA
Lilly’s Donanemab Wins India Approval For Alzheimer’s
This article was first published on: GuruFocus. Eli Lilly (NYSE:LLY) I achieved a meaningful international connection India’s drug regulator won…
Read More » -
USA
Eli Lilly’s amylin obesity drug shows up to 20% weight loss in study
The Eli Lilly Biotechnology Center was shown on March 1, 2023 in San Diego, California. Mike Blake | Reuters Eli…
Read More » -
USA
Lilly’s experimental drug shows promise with 20.1% weight loss in mid-stage trial
(Reuters) -Eli Lilly said on Thursday its experimental obesity drug helped patients lose 20.1% of their weight in a mid-stage…
Read More » -
USA
4 reasons to like Wells, Lilly’s latest launch, Boeing ramps production
Every day during the week, Jim Crammer and CNBC Investment Club released Homestretch, a processable afternoon update at the last…
Read More » -
USA
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
A sign with the company logo is sitting outside the center of Eli Lilly in Indiana, Indiana, Indiana on 17…
Read More » -
USA
Wall Street analysts rush to Eli Lilly’s defense but investors aren’t listening yet
Jim Cramer and CNBC Investment Club with Jim Cramer on weekdays are organizing a live stream at the “Morning Meeting”…
Read More » -
USA
Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity
Hand Lilly On Thursday, the diabetes medication that broke box office records showed that Mounjaro showed heart health benefits in…
Read More » -
USA
Chinese obesity may become a rival to Eli Lilly’s Zepbound
CR | Istock | Getty Images A version of this article was first published in the CNBC’s healthy return bulletin,…
Read More » -
USA
Abbott jumps on RFK Jr. health push — plus, reviews of Eli Lilly’s obesity drug data
Every day during the week, Jim Crammer and CNBC Investment Club released Homestretch, a processable afternoon update at the last…
Read More »
